v3.26.1
Statements of Cash Flows - USD ($)
 7 Months Ended 12 Months Ended
Dec. 31, 2024
Dec. 31, 2025
Cash flows from operating activities    
Net income $ 2,281,000 $ 5,538,000
Adjustments to reconcile net income to net cash used in operating activities:    
Income earned on investments held in Trust Account (3,194,000) (9,411,000)
Credit for over-allotment liability expired (136,000)
Formation expenses paid directly by Founders 16,000
Changes in operating assets and liabilities:    
Decrease (increase) in prepaid expenses (264,000) 62,000
Increase in accounts payable 4,000 8,000
Increase in accrued liabilities 129,000 192,000
Increase in deferred legal fees 231,000 1,573,000
Increase in deferred compensation – related parties 253,000 792,000
Net cash used in operating activities (680,000) (1,246,000)
Cash used in investing activities    
Investment of cash into Trust Account (221,100,000)
Net cash used in investing activities (221,100,000)
Cash flows from financing activities    
Proceeds from Note payable – related party 150,000 250,000
Repay Note payable – related party (209,000)
Proceeds from sale of Units net of underwriting discounts and reimbursements 218,000,000
Proceeds from sale of Private Placement Warrants 5,500,000
Payment of offering costs (573,000)
Net cash provided by financing activities 222,868,000 250,000
Net (decrease) increase in cash 1,088,000 (996,000)
Cash – beginning of period 1,088,000
Cash – end of period 1,088,000 92,000
Supplemental disclosure of noncash activities:    
Waiver of deferred offering fee 7,700,000
Deferred offering costs and general and administrative costs paid by Sponsor in exchange for issuance of Class B ordinary shares 9,000
Deferred underwriting payable 7,700,000
Deferred legal fees related to offering costs 408,000
Deferred offering costs paid directly by Sponsor through promissory note $ 59,000